2NV-34748-58368
3 vaccinations
12 coded responses
33 check-ins
12 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 432 / OH
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Very bad bruise at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Larger bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Site: Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Raynaud's Flare (intermittent, from day two post-shot)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Survey response — day 14, dose 1MedDRA: Temperature intolerance — Feeling: FairFree text: Heat intoleranceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — day 21, dose 1MedDRA: Emotional disorder — Feeling: GoodFree text: Emotional regulationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Cognitive disorder, Sensory overload, Temperature intolerance — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Cognitive issues - problems with sensory overload; heat intoleranceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Temperature intolerance — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Heat intoleranceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — day 7, dose 2MedDRA: Temperature intolerance — Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Heat intoleranceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Dysmenorrhoea, Hypersensitivity, Nasopharyngitis, Pre-existing disease, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: - Terrible menstrual pain foe the last three cycles - A cold that will not go away (3 weeks in the running)- Elevated allergies (skin rash)MedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
- 2021-10-21
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2021-10-22
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body achesAdult check-in
- 2021-10-25
- 2021-10-26
- 2021-10-28
- 2021-10-31
- 2021-11-05
- 2021-11-19
-
2021-12-03
Survey response — day 42, dose 3MedDRA: Lethargy — Feeling: FairFree text: LethargyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Survey response — 3 months, dose 3MedDRA: Food intolerance — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increased food sensitivitiesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Very bad bruise at the injection site
Systemic reaction (other): Larger bruise at injection site
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Raynaud's Flare (intermittent, from day two post-shot)
Release 7 — day 14, dose 1
Symptoms: Heat intolerance
Release 7 — day 21, dose 1
Symptoms: Emotional regulation
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Cognitive issues - problems with sensory overload; heat intolerance
Systemic reaction (other): Heat intolerance
Release 8 — day 7, dose 2
Systemic reaction (other): Heat intolerance
Release 9 — 3 months, dose 2
Symptoms: - Terrible menstrual pain foe the last three cycles - A cold that will not go away (3 weeks in the running)- Elevated allergies (skin rash)
Release 10 — day 42, dose 3
Symptoms: Lethargy
Release 11 — 3 months, dose 3
Symptoms: Increased food sensitivities
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Emotional disorder | ✓ | ✓ | ✓ |
| SD | Food intolerance | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Temperature intolerance | ✓ | ✓ | ✓ |
| SRO | Cognitive disorder | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Sensory overload | ✓ | ✓ | ✓ |
| SRO | Temperature intolerance | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release